SYRS

Syros Pharmaceuticals (SYRS)

About Syros Pharmaceuticals (SYRS)

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.

Details

Daily high

$0.12

Daily low

$0.10

Price at open

$0.11

52 Week High

$6.93

52 Week Low

$0.07

Market cap

3.4M

Dividend yield

0.00%

Volume

11.5M

Avg. volume

66.6M

P/E ratio

-.04

Syros Pharmaceuticals News